JPMorgan Asia Growth & Income plc
£5.13-£0.15 (-2.86%)
JPMorgan Asia Growth & Income plc’s quoted price sits in the lower half of its reported 52-week range, 21.34% below the high.
LSE · JCGI.L · GBp
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 01:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · GBp. Historical prices are not a forecast.
JPMorgan China Growth & Income plc’s quoted price sits in the lower half of its reported 52-week range, 33.36% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
JPMorgan China Growth & Income plc’s forward annual dividend is £0.11 per share, paid quarterly. The forward yield is 5.21% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow JPMorgan China Growth & Income plc’s reporting calendar.
THE COMPANY BEHIND THE TICKER
JPMorgan China Growth & Income plc is a UK-domiciled investment trust, established on October 1, 1993. This closed-ended equity fund is managed by JPMorgan Funds Limited, with support from co-manager JPMorgan Asset Management (UK) Limited. Its primary objective is to invest in public stock markets across the Greater China region, concentrating mainly on growth-oriented companies operating in diverse industries. The fund constructs its portfolio using comprehensive fundamental analysis, carefully evaluating factors such as the clarity of earnings and cash flow, the strength of balance sheets, and brand equity. Its investment performance is benchmarked against the MSCI Golden Dragon Index.
Latest available per-share figures in GBP. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:18 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
£5.13-£0.15 (-2.86%)
JPMorgan Asia Growth & Income plc’s quoted price sits in the lower half of its reported 52-week range, 21.34% below the high.
£0.92+£0.01 (+1.1%)
Castelnau Group Limited’s quoted price sits in the upper half of its reported 52-week range, 6.27% below the high.
£1.09£0.00 (0.0%)
Tufton Assets Limited’s quoted price sits in the upper half of its reported 52-week range, 1.58% below the high.
£1.14-£0.01 (-0.44%)
Real Estate Credit Investments Limited’s quoted price sits in the lower half of its reported 52-week range, 14.02% below the high.
£7.05£0.00 (0.0%)
B.P. Marsh & Partners PLC’s quoted price sits in the upper half of its reported 52-week range, 0.7% below the high.
£14.65-£0.05 (-0.34%)
Brooks Macdonald Group plc’s quoted price sits in the lower half of its reported 52-week range, 17.7% below the high.
£4.91£0.00 (0.0%)
Volta Finance Limited’s quoted price sits in the upper half of its reported 52-week range, 29.86% below the high.
£3.78-£0.07 (-1.91%)
City Natural Resources Growth & Income PLC’s quoted price sits in the upper half of its reported 52-week range, 19.14% below the high.